Adenovirus E1B 55-Kilodalton Oncoprotein Inhibits p53 Acetylation by PCAF

REFERENCES

• Ait-Si-Ali, S., Ramirez, S., Barre, F. X., Dkhissi, F., Magnaghi-Jaulin, L., Girault, J. A., Robin, P., Knibiehler, M., Pritchard, L. L., Ducommun, B., Trouche, D., and Harel-Bellan, A.. 1998. Histone acetyltransferase activity of CBP is controlled by cycle-dependent kinases and oncoprotein E1A. Nature 396:184–186
   PubMedGoogle Scholar
• Bargonetti, J., Friedman, P. N., Kern, S. E., Vogelstein, B., and Prives, C.. 1991. Wild-type but not mutant p53 immunopurified proteins bind to sequences adjacent to the SV40 origin of replication. Cell 65:1083–1091
   PubMed Web of Science ®Google Scholar
• Barker, D. D., and Berk, A. J.. 1987. Adenovirus proteins from both E1B reading frames are required for transformation of rodent cells by viral infection and DNA transfection. Virology 156:107–121
   PubMed Web of Science ®Google Scholar
• Candau, R., Zhou, J. X., Allis, C. D., and Berger, S. L.. 1997. Histone acetyltransferase activity and interaction with ADA2 are critical for GCN5 function in vivo. EMBO J. 16:555–565
   PubMedGoogle Scholar
• Chakravarti, D., Ogryzko, V., Kao, H. Y., Nash, A., Chen, H., Nakatani, Y., and Evans, R. M.. 1999. A viral mechanism for inhibition of p300 and PCAF acetyltransferase activity. Cell 96:393–403
   PubMed Web of Science ®Google Scholar
• Davie, J. R.. 1998. Covalent modifications of histones: expression from chromatin templates. Curr. Opin. Genet. Dev. 8:173–178
   PubMed Web of Science ®Google Scholar
• Debbas, M., and White, E.. 1993. Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. Genes Dev. 7:546–554
   PubMed Web of Science ®Google Scholar
• Dhalluin, C., Carlson, J. E., Zeng, L., He, C., Aggarwal, A. K., and Zhou, M. M.. 1999. Structure and ligand of a histone acetyltransferase bromodomain. Nature 399:491–496
   PubMed Web of Science ®Google Scholar
• Dobbelstein, M., Roth, J., Kimberly, W. T., Levine, A. J., and Shenk, T.. 1997. Nuclear export of the E1B 55-kDa and E4 34-kDa adenoviral oncoproteins mediated by a rev-like signal sequence. EMBO J. 16:4276–4284
   PubMed Web of Science ®Google Scholar
• Farmer, G., Bargonetti, J., Zhu, H., Friedman, P., Prywes, R., and Prives, C.. 1992. Wild-type p53 activates transcription in vitro. Nature 358:83–86
   PubMed Web of Science ®Google Scholar
• Flint, J., and Shenk, T.. 1997. Viral transactivating proteins. Annu. Rev. Genet. 31:177–212
   PubMedGoogle Scholar
• Gallimore, P. H., Lecane, P. S., Roberts, S., Rookes, S. M., Grand, R. J., and Parkhill, J.. 1997. Adenovirus type 12 early region 1B 54K protein significantly extends the life span of normal mammalian cells in culture. J. Virol. 71:6629–6640
   PubMedGoogle Scholar
• Gottlieb, T. M., and Oren, M.. 1996. p53 in growth control and neoplasia. Biochim. Biophys. Acta 1287:77–102
   PubMed Web of Science ®Google Scholar
• Graham, F. L., Abrahams, P. J., Mulder, C., Heijneker, H. L., Warnaar, S. O., De Vries, F. A., Fiers, W., and Van Der Eb, A. J.. 1975. Studies on in vitro transformation by DNA and DNA fragments of human adenoviruses and simian virus 40. Cold Spring Harbor Symp. Quant. Biol. 39:637–650
   PubMedGoogle Scholar
• Graham, F. L., Smiley, J., Russell, W. C., and Nairn, R.. 1977. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36:59–74
   PubMed Web of Science ®Google Scholar
• Grand, R. J., Grant, M. L., and Gallimore, P. H.. 1994. Enhanced expression of p53 in human cells infected with mutant adenoviruses. Virology 203:229–240
   PubMedGoogle Scholar
• Gu, W., and Roeder, R. G.. 1997. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90:595–606
   PubMed Web of Science ®Google Scholar
• Hahn, W. C., Counter, C. M., Lundberg, A. S., Beijersbergen, R. L., Brooks, M. W., and Weinberg, R. A.. 1999. Creation of human tumour cells with defined genetic elements. Nature 400:464–468
   PubMed Web of Science ®Google Scholar
• Hamamori, Y., Sartorelli, V., Ogryzko, V., Puri, P. L., Wu, H. Y., Wang, J. Y., Nakatani, Y., and Kedes, L.. 1999. Regulation of histone acetyltransferases p300 and PCAF by the bHLH protein twist and adenoviral oncoprotein E1A. Cell 96:405–413
   PubMed Web of Science ®Google Scholar
• Hupp, T. R., Meek, D. W., Midgley, C. A., and Lane, D. P.. 1992. Regulation of the specific DNA binding function of p53. Cell 71:875–886
   PubMed Web of Science ®Google Scholar
• Iwabuchi, K., Li, B., Bartel, P., and Fields, S.. 1993. Use of the two-hybrid system to identify the domain of p53 involved in oligomerization. Oncogene 8:1693–1696
   PubMed Web of Science ®Google Scholar
• James, P., Halladay, J., and Craig, E. A.. 1996. Genomic libraries and a host strain designed for highly efficient two-hybrid selection in yeast. Genetics 144:1425–1436
   PubMed Web of Science ®Google Scholar
• Jiang, H., Lu, H., Schlitz, R. L., Pise-Masison, C. A., Ogryzko, V. V., Nakatani, Y., and Brady, J. N.. 1999. PCAF interacts with tax and stimulates tax transactivation in a histone acetyltransferase-independent manner. Mol. Cell. Biol. 19:8136–8145
   PubMed Web of Science ®Google Scholar
• Kao, C. C., Yew, P. R., and Berk, A. J.. 1990. Domains required for in vitro association between the cellular p53 and the adenovirus 2 E1B 55K proteins. Virology 179:806–814
   PubMed Web of Science ®Google Scholar
• Ko, L. J., and Prives, C.. 1996. p53: puzzle and paradigm. Genes Dev. 10:1054–1072
   PubMed Web of Science ®Google Scholar
• Kouzarides, T.. 2000. Acetylation: a regulatory modification to rival phosphorylation? EMBO J. 19:1176–1179
   PubMed Web of Science ®Google Scholar
• Kuo, M. H., and Allis, C. D.. 1998. Roles of histone acetyltransferases and deacetylases in gene regulation. Bioessays 20:615–626
   PubMed Web of Science ®Google Scholar
• Labbe, S., Zhu, Z., and Thiele, D. J.. 1997. Copper-specific transcriptional repression of yeast genes encoding critical components in the copper transport pathway. J. Biol. Chem. 272:15951–15958
   PubMed Web of Science ®Google Scholar
• Lane, D.. 1998. Awakening angels. Nature 394:616–617
   PubMed Web of Science ®Google Scholar
• Lane, D. P., and Crawford, L. V.. 1979. T antigen is bound to a host protein in SV40-transformed cells. Nature 278:261–263
   PubMed Web of Science ®Google Scholar
• Levine, A. J.. 1997. p53, the cellular gatekeeper for growth and division. Cell 88:323–331
   PubMed Web of Science ®Google Scholar
• Liao, D., Yu, A., and Weiner, A. M.. 1999. Coexpression of the adenovirus 12 E1B 55 kDa oncoprotein and cellular tumor suppressor p53 is sufficient to induce metaphase fragility of the human RNU2 locus. Virology 254:11–23
   PubMedGoogle Scholar
• Lin, J., Chen, J., Elenbaas, B., and Levine, A. J.. 1994. Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein. Genes Dev. 8:1235–1246
   PubMed Web of Science ®Google Scholar
• Linzer, D. I., and Levine, A. J.. 1979. Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells. Cell 17:43–52
   PubMed Web of Science ®Google Scholar
• Liu, L., Scolnick, D. M., Trievel, R. C., Zhang, H. B., Marmorstein, R., Halazonetis, T. D., and Berger, S. L.. 1999. p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage. Mol. Cell. Biol. 19:1202–1209
   PubMed Web of Science ®Google Scholar
• Lowe, S. W., and Ruley, H. E.. 1993. Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis. Genes Dev. 7:535–545
   PubMed Web of Science ®Google Scholar
• Mak, I., Mak, S., and Benchimol, S.. 1988. Expression of the cellular p53 protein in cells transformed by adenovirus 12 and viral DNA fragments. Virology 163:201–204
   PubMedGoogle Scholar
• Marcellus, R. C., Teodoro, J. G., Charbonneau, R., Shore, G. C., and Branton, P. E.. 1996. Expression of p53 in Saos-2 osteosarcoma cells induces apoptosis which can be inhibited by Bcl-2 or the adenovirus E1B-55 kDa protein. Cell Growth Differ. 7:1643–1650
   PubMedGoogle Scholar
• Martin, M. E., and Berk, A. J.. 1998. Adenovirus E1B 55K represses p53 activation in vitro. J. Virol. 72:3146–3154
   PubMed Web of Science ®Google Scholar
• Martin, M. E., and Berk, A. J.. 1999. Corepressor required for adenovirus E1B 55,000-molecular-weight protein repression of basal transcription. Mol. Cell. Biol. 19:3403–3414
   PubMedGoogle Scholar
• Mietz, J. A., Unger, T., Huibregtse, J. M., and Howley, P. M.. 1992. The transcriptional transactivation function of wild-type p53 is inhibited by SV40 large T-antigen and by HPV-16 E6 oncoprotein. EMBO J. 11:5013–5020
   PubMed Web of Science ®Google Scholar
• Prives, C.. 1998. Signaling to p53: breaking the MDM2-p53 circuit. Cell 95:5–8
   PubMed Web of Science ®Google Scholar
• Puri, P. L., Sartorelli, V., Yang, X. J., Hamamori, Y., Ogryzko, V. V., Howard, B. H., Kedes, L., Wang, J. Y., Graessmann, A., Nakatani, Y., and Levrero, M.. 1997. Differential roles of p300 and PCAF acetyltransferases in muscle differentiation. Mol. Cell 1:35–45
   PubMed Web of Science ®Google Scholar
• Reid, J. L., Bannister, A. J., Zegerman, P., Martinez-Balbas, M. A., and Kouzarides, T.. 1998. E1A directly binds and regulates the P/CAF acetyltransferase. EMBO J. 17:4469–4477
   PubMedGoogle Scholar
• Ricciardi, R. P.. 1995. Transformation and tumorigenesis mediated by the adenovirus E1A and E1B oncogenes DNA tumor viruses: oncogenic mechanisms. Barbanti-Brodano, G. et al. 195–225 Plenum Press, New York, N.Y
   Google Scholar
• Roulston, A., Marcellus, R. C., and Branton, P. E.. 1999. Viruses and apoptosis. Annu. Rev. Microbiol. 53:577–628
   PubMed Web of Science ®Google Scholar
• Sakaguchi, K., Herrera, J. E., Saito, S., Miki, T., Bustin, M., Vassilev, A., Anderson, C. W., and Appella, E.. 1998. DNA damage activates p53 through a phosphorylation-acetylation cascade. Genes Dev. 12:2831–2841
   PubMed Web of Science ®Google Scholar
• Sarnow, P., Ho, Y. S., Williams, J., and Levine, A. J.. 1982. Adenovirus E1B-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells. Cell 28:387–394
   PubMed Web of Science ®Google Scholar
• Sarnow, P., Sullivan, C. A., and Levine, A. J.. 1982. A monoclonal antibody detecting the adenovirus type 5-E1b-58Kd tumor antigen: characterization of the E1b-58Kd tumor antigen in adenovirus-infected and -transformed cells. Virology 120:510–517
   PubMedGoogle Scholar
• Sartorelli, V., Puri, P. L., Hamamori, Y., Ogryzko, V., Chung, G., Nakatani, Y., Wang, J. Y., and Kedes, L.. 1999. Acetylation of MyoD directed by PCAF is necessary for the execution of the muscle program. Mol. Cell 4:725–734
   PubMed Web of Science ®Google Scholar
• Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J., and Howley, P. M.. 1990. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63:1129–1136
   PubMed Web of Science ®Google Scholar
• Schmieg, F. I., and Simmons, D. T.. 1988. Characterization of the in vitro interaction between SV40 T antigen and p53: mapping the p53 binding site. Virology 164:132–140
   PubMedGoogle Scholar
• Shieh, S. Y., Ikeda, M., Taya, Y., and Prives, C.. 1997. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 91:325–334
   PubMed Web of Science ®Google Scholar
• Steegenga, W. T., van Laar, T., Riteco, N., Mandarino, A., Shvarts, A., van der Eb, A. J., and Jochemsen, A. G.. 1996. Adenovirus E1A proteins inhibit activation of transcription by p53. Mol. Cell. Biol. 16:2101–2109
   PubMedGoogle Scholar
• Steegenga, W. T., Van Laar, T., Shvarts, A., Terleth, C., Van der Eb, A. J., and Jochemsen, A. G.. 1995. Distinct modulation of p53 activity in transcription and cell-cycle regulation by the large (54 kDa) and small (21 kDa) adenovirus E1B proteins. Virology 212:543–554
   PubMedGoogle Scholar
• Tan, T. H., Wallis, J., and Levine, A. J.. 1986. Identification of the p53 protein domain involved in formation of the simian virus 40 large T-antigen–p53 protein complex. J. Virol. 59:574–583
   PubMedGoogle Scholar
• Teodoro, J. G., and Branton, P. E.. 1997. Regulation of p53-dependent apoptosis, transcriptional repression, and cell transformation by phosphorylation of the 55-kilodalton E1B protein of human adenovirus type 5. J. Virol. 71:3620–3627
   PubMedGoogle Scholar
• Teodoro, J. G., Shore, G. C., and Branton, P. E.. 1995. Adenovirus E1A proteins induce apoptosis by both p53-dependent and p53-independent mechanisms. Oncogene 11:467–474
   PubMed Web of Science ®Google Scholar
• Torchia, J., Glass, C., and Rosenfeld, M. G.. 1998. Co-activators and co-repressors in the integration of transcriptional responses. Curr. Opin. Cell Biol. 10:373–383
   PubMed Web of Science ®Google Scholar
• van den Elsen, P. J., Houweling, A., and van der Eb, A. J.. 1983. Morphological transformation of human adenoviruses is determined to a large extent by gene products of region E1a. Virology 131:242–246
   PubMedGoogle Scholar
• van den Heuvel, S. J., van Laar, T., The, I., and van der Eb, A. J.. 1993. Large E1B proteins of adenovirus types 5 and 12 have different effects on p53 and distinct roles in cell transformation. J. Virol. 67:5226–5234
   PubMedGoogle Scholar
• Vassilev, A., Yamauchi, J., Kotani, T., Prives, C., Avantaggiati, M. L., Qin, J., and Nakatani, Y.. 1998. The 400 kDa subunit of the PCAF histone acetylase complex belongs to the ATM superfamily. Mol. Cell 2:869–875
   PubMedGoogle Scholar
• Wang, L., Mizzen, C., Ying, C., Candau, R., Barlev, N., Brownell, J., Allis, C. D., and Berger, S. L.. 1997. Histone acetyltransferase activity is conserved between yeast and human GCN5 and is required for complementation of growth and transcriptional activation. Mol. Cell. Biol. 17:519–527
   PubMedGoogle Scholar
• Waterman, M. J., Stavridi, E. S., Waterman, J. L., and Halazonetis, T. D.. 1998. ATM-dependent activation of p53 involves dephosphorylation and association with 14-3-3 proteins. Nat. Genet. 19:175–178
   PubMed Web of Science ®Google Scholar
• Weissman, B. E., Saxon, P. J., Pasquale, S. R., Jones, G. R., Geiser, A. G., and Stanbridge, E. J.. 1987. Introduction of a normal human chromosome 11 into a Wilms' tumor cell line controls its tumorigenic expression. Science 236:175–180
   PubMed Web of Science ®Google Scholar
• Werness, B. A., Levine, A. J., and Howley, P. M.. 1990. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248:76–79
   PubMed Web of Science ®Google Scholar
• Wienzek, S., Roth, J., and Dobbelstein, M.. 2000. E1B 55-kilodalton oncoproteins of adenovirus types 5 and 12 inactivate and relocalize p53, but not p51 or p73, and cooperate with E4orf6 proteins to destabilize p53. J. Virol. 74:193–202
   PubMedGoogle Scholar
• Yang, X. J., Ogryzko, V. V., Nishikawa, J., Howard, B. H., and Nakatani, Y.. 1996. A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A. Nature 382:319–324
   PubMed Web of Science ®Google Scholar
• Yew, P. R., and Berk, A. J.. 1992. Inhibition of p53 transactivation required for transformation by adenovirus early 1B protein. Nature 357:82–85
   PubMed Web of Science ®Google Scholar
• Yew, P. R., Kao, C. C., and Berk, A. J.. 1990. Dissection of functional domains in the adenovirus 2 early 1B 55K polypeptide by suppressor-linker insertional mutagenesis. Virology 179:795–805
   PubMed Web of Science ®Google Scholar
• Yew, P. R., Liu, X., and Berk, A. J.. 1994. Adenovirus E1B oncoprotein tethers a transcriptional repression domain to p53. Genes Dev. 8:190–202
   PubMed Web of Science ®Google Scholar
• Zantema, A., Fransen, J. A., Davis-Olivier, A., Ramaekers, F. C., Vooijs, G. P., DeLeys, B., and Van der Eb, A. J.. 1985. Localization of the E1B proteins of adenovirus 5 in transformed cells, as revealed by interaction with monoclonal antibodies. Virology 142:44–58
   PubMedGoogle Scholar
• Zantema, A., Schrier, P. I., Davis-Olivier, A., van Laar, T., Vaessen, R. T. M. J., and van der Eb, A. J.. 1985. Adenovirus serotype determines association and localization of the large E1B tumor antigen with cellular tumor antigen p53 in transformed cells. Mol. Cell. Biol. 5:3084–3091
   PubMedGoogle Scholar